Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: Ketamine Alcohol (in Treatment-Resistant Depression) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ketamine in treatment-resistant depression with comorbid alcohol use is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Mark Niciu | Conditions: Magnetic Resonance Imaging, Major Depression | Phase 2 | Status: RECRUITING